Previous Close | 26.95 |
Open | 26.97 |
Bid | 27.02 x 1700 |
Ask | 27.09 x 600 |
Day's Range | 26.92 - 27.05 |
52 Week Range | 6.08 - 33.12 |
Volume | |
Avg. Volume | 1,438,159 |
Market Cap | 1.073B |
Beta (5Y Monthly) | 1.51 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.37 |
Earnings Date | Jul 30, 2024 - Aug 05, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 21.83 |
This acquisition is expected to enhance Boston Scientific's (BSX) market position and revenue streams in North America and Europe.
Silk Road Medical (SILK) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
FEATURE Boston Scientific announced an agreement to acquire Silk Road Medical a medical device company, in a deal valued at just under $1.2 billion. Silk Road Medical develops products used to help prevent stroke in patients with carotid artery disease through a minimally invasive procedure.